IFITM3 and hepatocellular carcinoma: Our suggested mRNA signature including CTNNB1, RhoA, SPINK1, IFITM3 and SERPIND1, alongside other platelets mRNA, can be utilized as biomarkers for comparison of hepatic cirrhosis and HCC.